Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

IL13-zetakine

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The interleukin-13 receptor alpha2 (IL13Rα2) is a cell surface receptor that is over-expressed by a subset of high-grade gliomas… Expand
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • figure 5
2013
2013
The prognosis of patients with high-grade glioma remains grim despite improvements in standard therapies including surgery… Expand
Highly Cited
2012
Highly Cited
2012
Purpose: To evaluate IL13Rα2 as an immunotherapeutic target for eliminating glioma stem–like cancer initiating cells (GSC) of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
Central nervous system loco-regional disease relapse is a common etiology of treatment failure for medulloblastoma (MB)/primitive… Expand
2007
2007
Background The role of co-stimulation in CD4+ T cell activation by professional APC is well established, while less is known of… Expand
2006
2006
Immunotherapy utilizing genetically-modified cytolytic T-lymphocytes (CTL) provides a promising therapeutic approach for treating… Expand
Highly Cited
2004
Highly Cited
2004
The interleukin (IL) 13 receptor α2 (IL13Rα2) is a glioma-restricted cell-surface epitope not otherwise detected within the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5